Continuous	continuous	O	O	O	O
ambulatory	ambulatory	O	O	O	O
ECG	ecg	O	O	O	O
monitoring	monitoring	O	O	O	O
during	during	O	O	O	O
fluorouracil	fluorouracil	O	O	OTHERS	I
therapy	therapy	O	O	O	O
:	:	O	O	O	O
a	a	O	O	O	O
prospective	prospective	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

Although	although	O	O	O	O
there	there	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
anecdotal	anecdotal	O	O	O	O
reports	reports	O	O	O	O
of	of	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
fluorouracil	fluorouracil	O	O	OTHERS	I
(	(	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
therapy	therapy	O	O	O	O
,	,	O	O	O	O
this	this	O	O	O	O
phenomenon	phenomenon	O	O	O	O
has	has	O	O	O	O
not	not	O	O	O	O
been	been	O	O	O	O
studied	studied	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
systematic	systematic	O	O	O	O
fashion	fashion	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
prospectively	prospectively	O	O	O	O
performed	performed	O	O	O	O
continuous	continuous	O	O	O	O
ambulatory	ambulatory	O	O	O	O
ECG	ecg	O	O	O	O
monitoring	monitoring	O	O	O	O
on	on	O	O	O	O
25	25	O	O	O	O
patients	patients	O	O	O	O
undergoing	undergoing	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
for	for	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
solid	solid	O	O	O	O
tumors	tumors	O	DISEASE	OTHERS	I
in	in	O	O	O	O
order	order	O	O	O	O
to	to	O	O	O	O
assess	assess	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
ischemic	ischemic	O	O	OTHERS	I
ST	st	O	O	O	O
changes	changes	O	O	O	O
.	.	O	O	O	O

Patients	patients	O	O	O	O
were	were	O	O	O	O
monitored	monitored	O	O	O	O
for	for	O	O	O	O
23	23	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
4	4	O	O	O	O
hours	hours	O	O	O	O
before	before	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
98	98	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
9	9	O	O	O	O
hours	hours	O	O	O	O
during	during	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
.	.	O	O	O	O

Anginal	anginal	O	O	OTHERS	I
episodes	episodes	O	O	O	O
were	were	O	O	O	O
rare	rare	O	O	O	O
:	:	O	O	O	O
only	only	O	O	O	O
one	one	O	O	O	O
patient	patient	O	O	O	O
had	had	O	O	O	O
angina	angina	O	O	OTHERS	I
(	(	O	O	O	O
during	during	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
asymptomatic	asymptomatic	O	O	O	O
ST	st	O	O	O	O
changes	changes	O	O	O	O
(	(	O	O	O	O
greater	greater	O	O	O	O
than	than	O	O	O	O
or	or	O	O	O	O
equal	equal	O	O	O	O
to	to	O	O	O	O
1	1	O	O	O	O
mm	mm	O	O	OTHERS	I
ST	st	O	O	O	O
deviation	deviation	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
common	common	O	O	O	O
:	:	O	O	O	O
six	six	O	O	O	O
of	of	O	O	O	O
25	25	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
24	24	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
had	had	O	O	O	O
ST	st	O	O	O	O
changes	changes	O	O	O	O
before	before	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
v	v	O	O	O	O
17	17	O	O	O	O
(	(	O	O	O	O
68	68	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
during	during	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
.002	.002	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
ischemic	ischemic	O	O	OTHERS	I
episodes	episodes	O	O	O	O
per	per	O	O	O	O
patient	patient	O	O	O	O
per	per	O	O	O	O
hour	hour	O	O	O	O
was	was	O	O	O	O
0.05	0.05	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O

0.02	0.02	O	O	O	O
prior	prior	O	O	O	O
to	to	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
v	v	O	O	O	O
0.13	0.13	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.03	0.03	O	O	O	O
during	during	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
.001	.001	O	O	O	O
)	)	O	O	O	O
;	;	O	O	O	O
the	the	O	O	O	O
duration	duration	O	O	O	O
of	of	O	O	O	O
ECG	ecg	O	O	O	O
changes	changes	O	O	O	O
was	was	O	O	O	O
0.6	0.6	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.3	0.3	O	O	O	O
minutes	minutes	O	O	O	O
per	per	O	O	O	O
patient	patient	O	O	O	O
per	per	O	O	O	O
hour	hour	O	O	O	O
before	before	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
v	v	O	O	O	O
1.9	1.9	O	O	O	O
+	+	O	O	O	O
/-	/-	O	O	O	O
0.5	0.5	O	O	O	O
minutes	minutes	O	O	O	O
per	per	O	O	O	O
patient	patient	O	O	O	O
per	per	O	O	O	O
hour	hour	O	O	O	O
during	during	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
.01	.01	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

ECG	ecg	O	O	O	O
changes	changes	O	O	O	O
were	were	O	O	O	O
more	more	O	O	O	O
common	common	O	O	O	O
among	among	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
known	known	O	O	O	O
coronary	coronary	O	DISEASE	OTHERS	I
artery	artery	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
.	.	O	O	O	O

There	there	O	O	O	O
were	were	O	O	O	O
two	two	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
sudden	sudden	O	O	OTHERS	I
death	death	O	DISEASE	OTHERS	I
,	,	O	O	O	O
both	both	O	O	O	O
of	of	O	O	O	O
which	which	O	O	O	O
occurred	occurred	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
end	end	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
course	course	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
conclude	conclude	O	O	O	O
that	that	O	O	O	O
5-FU	5-fu	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
is	is	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
silent	silent	O	O	O	O
ST	st	O	O	O	O
segment	segment	O	O	O	O
deviation	deviation	O	O	O	O
suggestive	suggestive	O	O	O	O
of	of	O	O	O	O
ischemia	ischemia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
particularly	particularly	O	O	O	O
among	among	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
coronary	coronary	O	DISEASE	OTHERS	I
artery	artery	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
mechanism	mechanism	O	O	O	O
and	and	O	O	O	O
clinical	clinical	O	O	O	O
significance	significance	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
ECG	ecg	O	O	O	O
changes	changes	O	O	O	O
remain	remain	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
determined	determined	O	O	O	O
.	.	O	O	O	O

